Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

Purpose To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Materials and Methods Quantification of liver fat was compared by liver biopsy, proton MRS, and MRI using in‐phase/out‐of‐phase (IP/OP) and plus/minus fat saturation...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 28; no. 4; pp. 937 - 945
Main Authors Cowin, Gary J., Jonsson, Julie R., Bauer, Judith D., Ash, Susan, Ali, Azmat, Osland, Emma J., Purdie, David M., Clouston, Andrew D., Powell, Elizabeth E., Galloway, Graham J.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.10.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Materials and Methods Quantification of liver fat was compared by liver biopsy, proton MRS, and MRI using in‐phase/out‐of‐phase (IP/OP) and plus/minus fat saturation (±FS) techniques. The reproducibility of each MR measure was also determined. An additional group of overweight patients with steatosis underwent hepatic MRI and MRS before and after a six‐month weight‐loss program. Results A close correlation was demonstrated between histological assessment of steatosis and measurement of intrahepatocellular lipid (IHCL) by MRS (rs = 0.928, P < 0.0001) and MRI (IP/OP rs = 0.942, P < 0.0001; FS rs = 0.935, P < 0.0001). Following weight reduction, four of five patients with >5% weight loss had a decrease in IHCL of ≥50%. Conclusion These findings suggest that standard MRI protocols provide a rapid, safe, and quantitative assessment of hepatic steatosis. This is important because MRS is not available on all clinical MRI systems. This will enable noninvasive monitoring of the effects of interventions such as weight loss or pharmacotherapy in patients with fatty liver diseases. J. Magn. Reson. Imaging 2008;28:937–945. © 2008 Wiley‐Liss, Inc.
AbstractList To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Quantification of liver fat was compared by liver biopsy, proton MRS, and MRI using in-phase/out-of-phase (IP/OP) and plus/minus fat saturation (+/-FS) techniques. The reproducibility of each MR measure was also determined. An additional group of overweight patients with steatosis underwent hepatic MRI and MRS before and after a six-month weight-loss program. A close correlation was demonstrated between histological assessment of steatosis and measurement of intrahepatocellular lipid (IHCL) by MRS (r(s) = 0.928, P < 0.0001) and MRI (IP/OP r(s) = 0.942, P < 0.0001; FS r(s) = 0.935, P < 0.0001). Following weight reduction, four of five patients with >5% weight loss had a decrease in IHCL of >or=50%. These findings suggest that standard MRI protocols provide a rapid, safe, and quantitative assessment of hepatic steatosis. This is important because MRS is not available on all clinical MRI systems. This will enable noninvasive monitoring of the effects of interventions such as weight loss or pharmacotherapy in patients with fatty liver diseases.
PURPOSETo compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content.MATERIALS AND METHODSQuantification of liver fat was compared by liver biopsy, proton MRS, and MRI using in-phase/out-of-phase (IP/OP) and plus/minus fat saturation (+/-FS) techniques. The reproducibility of each MR measure was also determined. An additional group of overweight patients with steatosis underwent hepatic MRI and MRS before and after a six-month weight-loss program.RESULTSA close correlation was demonstrated between histological assessment of steatosis and measurement of intrahepatocellular lipid (IHCL) by MRS (r(s) = 0.928, P < 0.0001) and MRI (IP/OP r(s) = 0.942, P < 0.0001; FS r(s) = 0.935, P < 0.0001). Following weight reduction, four of five patients with >5% weight loss had a decrease in IHCL of >or=50%.CONCLUSIONThese findings suggest that standard MRI protocols provide a rapid, safe, and quantitative assessment of hepatic steatosis. This is important because MRS is not available on all clinical MRI systems. This will enable noninvasive monitoring of the effects of interventions such as weight loss or pharmacotherapy in patients with fatty liver diseases.
Purpose To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Materials and Methods Quantification of liver fat was compared by liver biopsy, proton MRS, and MRI using in‐phase/out‐of‐phase (IP/OP) and plus/minus fat saturation (±FS) techniques. The reproducibility of each MR measure was also determined. An additional group of overweight patients with steatosis underwent hepatic MRI and MRS before and after a six‐month weight‐loss program. Results A close correlation was demonstrated between histological assessment of steatosis and measurement of intrahepatocellular lipid (IHCL) by MRS (rs = 0.928, P < 0.0001) and MRI (IP/OP rs = 0.942, P < 0.0001; FS rs = 0.935, P < 0.0001). Following weight reduction, four of five patients with >5% weight loss had a decrease in IHCL of ≥50%. Conclusion These findings suggest that standard MRI protocols provide a rapid, safe, and quantitative assessment of hepatic steatosis. This is important because MRS is not available on all clinical MRI systems. This will enable noninvasive monitoring of the effects of interventions such as weight loss or pharmacotherapy in patients with fatty liver diseases. J. Magn. Reson. Imaging 2008;28:937–945. © 2008 Wiley‐Liss, Inc.
Author Powell, Elizabeth E.
Jonsson, Julie R.
Osland, Emma J.
Purdie, David M.
Galloway, Graham J.
Ash, Susan
Bauer, Judith D.
Cowin, Gary J.
Ali, Azmat
Clouston, Andrew D.
Author_xml – sequence: 1
  givenname: Gary J.
  surname: Cowin
  fullname: Cowin, Gary J.
  email: gary.cowin@cmr.uq.edu.au
  organization: Centre for Magnetic Resonance, University of Queensland, Queensland, Australia
– sequence: 2
  givenname: Julie R.
  surname: Jonsson
  fullname: Jonsson, Julie R.
  organization: School of Medicine, Southern Division, University of Queensland, Queensland, Australia
– sequence: 3
  givenname: Judith D.
  surname: Bauer
  fullname: Bauer, Judith D.
  organization: Wesley Research Institute, Queensland, Australia
– sequence: 4
  givenname: Susan
  surname: Ash
  fullname: Ash, Susan
  organization: School of Public Health, Queensland University of Technology, Queensland, Australia
– sequence: 5
  givenname: Azmat
  surname: Ali
  fullname: Ali, Azmat
  organization: Department of Nutrition Services, Princess Alexandra Hospital, Queensland, Australia
– sequence: 6
  givenname: Emma J.
  surname: Osland
  fullname: Osland, Emma J.
  organization: Department of Nutrition Services, Princess Alexandra Hospital, Queensland, Australia
– sequence: 7
  givenname: David M.
  surname: Purdie
  fullname: Purdie, David M.
  organization: Genentech Inc., South San Francisco, California, USA
– sequence: 8
  givenname: Andrew D.
  surname: Clouston
  fullname: Clouston, Andrew D.
  organization: School of Medicine, Southern Division, University of Queensland, Queensland, Australia
– sequence: 9
  givenname: Elizabeth E.
  surname: Powell
  fullname: Powell, Elizabeth E.
  organization: School of Medicine, Southern Division, University of Queensland, Queensland, Australia
– sequence: 10
  givenname: Graham J.
  surname: Galloway
  fullname: Galloway, Graham J.
  organization: Centre for Magnetic Resonance, University of Queensland, Queensland, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18821619$$D View this record in MEDLINE/PubMed
BookMark eNp9kElLAzEYQIMo7hd_gMzJgzCaZbIdRawLbrggeAmZSVqiM0lNpmr_vamtevOUhLzvwfc2wLIP3gKwg-ABghAfvnTRHWBEK7wE1hHFuMRUsOV8h5SUSEC-BjZSeoEQSlnRVbCGhMCIIbkOLq70yNveNUW0KXjtG1u4To-cHxXamyKNbdPHkJownhbDEIsueNeHOPtv3buNReqt7kNyaQusDHWb7Pbi3ASPg5OH47Py8ub0_PjosmwqgnBpDKlkxSVjTBPBK8hpJSSssamlZFSbmgktraF1LRrBJRlW-YmsMMRQyWqyCfbm3nEMbxObetW51Ni21d6GSVIsWyDFKIP7c7DJC6Roh2oc825xqhBUs3JqVk59l8vw7sI6qTtr_tBFqgygOfDhWjv9R6Uuru7Of6TlfMblSp-_Mzq-KsYJp-rp-lRx-nT7zO-hGpAvpIOKYg
CitedBy_id crossref_primary_10_1007_s10334_015_0508_1
crossref_primary_10_1111_j_1751_2980_2009_00402_x
crossref_primary_10_1093_jn_nxaa414
crossref_primary_10_1016_j_ultrasmedbio_2015_11_004
crossref_primary_10_3748_wjg_v27_i35_5803
crossref_primary_10_1007_s40261_019_00785_6
crossref_primary_10_3390_jcm10050965
crossref_primary_10_1002_nbm_2837
crossref_primary_10_1371_journal_pone_0141691
crossref_primary_10_1111_hepr_13408
crossref_primary_10_1007_s00247_011_2021_7
crossref_primary_10_1007_s00330_010_1941_1
crossref_primary_10_1016_j_acra_2011_07_009
crossref_primary_10_1002_jmri_22580
crossref_primary_10_1210_jc_2009_0438
crossref_primary_10_1148_radiol_13121360
crossref_primary_10_2214_AJR_11_6729
crossref_primary_10_1016_j_bpg_2014_07_008
crossref_primary_10_2310_JIM_0b013e318216ad1d
crossref_primary_10_1148_rg_295085186
crossref_primary_10_1111_apt_12186
crossref_primary_10_1002_jmri_24908
crossref_primary_10_1016_j_ultrasmedbio_2018_03_011
crossref_primary_10_3390_ijms17050633
crossref_primary_10_1148_rg_296095520
crossref_primary_10_28982_josam_804878
crossref_primary_10_12998_wjcc_v10_i25_8906
crossref_primary_10_3748_wjg_v22_i39_8812
crossref_primary_10_1155_2017_1364818
crossref_primary_10_4081_cp_2013_e17
crossref_primary_10_1016_j_jhep_2009_05_023
crossref_primary_10_1016_j_mric_2010_08_013
crossref_primary_10_2147_IJGM_S382287
crossref_primary_10_1016_j_acra_2010_03_019
crossref_primary_10_1089_dia_2013_0039
crossref_primary_10_1002_jmri_21957
crossref_primary_10_1002_nbm_3069
crossref_primary_10_1016_j_jhep_2009_09_006
crossref_primary_10_1038_oby_2011_302
crossref_primary_10_3390_diagnostics11050842
crossref_primary_10_14366_usg_19002
crossref_primary_10_33590_emj_10310531
crossref_primary_10_1007_s00592_013_0516_4
crossref_primary_10_1111_j_1872_034X_2009_00620_x
crossref_primary_10_1002_jmri_24136
crossref_primary_10_3389_fonc_2022_873524
crossref_primary_10_3390_ijerph13100999
crossref_primary_10_1007_s00261_023_04009_6
crossref_primary_10_1007_s10067_021_05764_x
crossref_primary_10_1097_RCT_0b013e3181cefb89
crossref_primary_10_1148_radiol_2018181134
crossref_primary_10_1016_j_ultras_2016_10_009
crossref_primary_10_15380_2277_5706_JCSR_14_072
crossref_primary_10_1586_17474124_2015_1049155
crossref_primary_10_1016_j_ejim_2020_06_004
crossref_primary_10_1039_C5AN01080B
crossref_primary_10_1245_s10434_016_5441_7
crossref_primary_10_1007_s00261_012_9930_2
crossref_primary_10_1016_j_cgh_2014_02_024
crossref_primary_10_1007_s11888_009_0015_8
crossref_primary_10_3348_jksr_2017_76_1_14
crossref_primary_10_1586_17474124_2016_1099433
crossref_primary_10_1016_j_jhep_2013_04_013
crossref_primary_10_1148_radiol_12110673
crossref_primary_10_1097_RMR_0000000000000016
crossref_primary_10_4137_MRI_S19362
crossref_primary_10_1016_j_jhep_2010_04_018
crossref_primary_10_1007_s00268_010_0656_4
crossref_primary_10_1016_j_jrras_2023_100658
crossref_primary_10_3390_ijms17091554
crossref_primary_10_1002_jum_15364
crossref_primary_10_1016_j_compbiomed_2016_02_013
crossref_primary_10_1111_imj_14709
crossref_primary_10_1111_hepr_12767
crossref_primary_10_1371_journal_pone_0181789
crossref_primary_10_1007_s12194_012_0191_0
crossref_primary_10_2337_dc10_0856
crossref_primary_10_1097_RCT_0000000000000423
crossref_primary_10_1007_s11547_015_0545_x
crossref_primary_10_1186_s12876_020_01204_3
crossref_primary_10_2214_AJR_16_17741
crossref_primary_10_33590_emjhepatol_10311541
crossref_primary_10_1002_mrm_23016
crossref_primary_10_1016_j_clinimag_2018_01_011
crossref_primary_10_3350_cmh_2017_0042
crossref_primary_10_1177_0884533612470464
crossref_primary_10_1148_radiol_12112344
crossref_primary_10_1053_j_sult_2016_08_003
crossref_primary_10_1371_journal_pone_0114436
crossref_primary_10_1016_j_remn_2012_04_006
crossref_primary_10_1002_jmri_23741
crossref_primary_10_1016_j_crad_2015_10_002
crossref_primary_10_1097_SLA_0000000000000525
crossref_primary_10_1097_TXD_0000000000001161
crossref_primary_10_2214_AJR_23_29607
crossref_primary_10_1016_j_remnie_2013_05_001
crossref_primary_10_1002_hep_25762
crossref_primary_10_1148_radiol_10091790
crossref_primary_10_1016_j_metabol_2009_05_032
crossref_primary_10_1053_j_gastro_2012_04_001
crossref_primary_10_1177_2042018811419157
crossref_primary_10_1007_s11901_016_0296_8
crossref_primary_10_1016_j_dld_2017_08_030
crossref_primary_10_1177_0284185115580488
crossref_primary_10_1016_j_jhep_2009_04_012
crossref_primary_10_1371_journal_pone_0059287
crossref_primary_10_3390_healthcare10020374
crossref_primary_10_1016_j_chemphyslip_2015_07_005
crossref_primary_10_1161_ATVBAHA_114_303034
crossref_primary_10_1097_RLI_0b013e3181df2afb
crossref_primary_10_1007_s00330_013_2826_x
crossref_primary_10_1371_journal_pone_0160789
crossref_primary_10_1038_ajg_2012_128
crossref_primary_10_1155_2016_8454751
crossref_primary_10_1002_jmri_23928
crossref_primary_10_1016_j_dld_2022_12_022
crossref_primary_10_1097_RCT_0b013e31825977c2
crossref_primary_10_1088_1361_6560_ac1023
crossref_primary_10_1016_j_ejrad_2011_02_065
crossref_primary_10_1007_s00330_009_1330_9
crossref_primary_10_1097_MPA_0000000000002305
crossref_primary_10_3748_wjg_v25_i11_1307
crossref_primary_10_1093_cdn_nzaa171
crossref_primary_10_3945_ajcn_113_080200
crossref_primary_10_1016_j_mcna_2013_09_001
crossref_primary_10_3748_wjg_v29_i22_3548
crossref_primary_10_2217_iim_11_13
crossref_primary_10_1007_s00261_016_0736_5
crossref_primary_10_1111_hepr_12338
crossref_primary_10_1007_s00117_015_0032_3
crossref_primary_10_1111_liv_13488
crossref_primary_10_1002_jmri_24737
crossref_primary_10_1097_MCO_0b013e32832eb587
crossref_primary_10_1242_dmm_026476
crossref_primary_10_1002_jmri_23524
crossref_primary_10_1148_radiol_11101942
crossref_primary_10_2337_db13_1483
crossref_primary_10_1007_s00261_015_0385_0
crossref_primary_10_1016_S1470_2045_09_70064_6
crossref_primary_10_1097_RLI_0b013e3181da1343
crossref_primary_10_1007_s00261_015_0506_9
crossref_primary_10_3748_wjg_v20_i36_12956
crossref_primary_10_1016_j_liver_2022_100091
crossref_primary_10_1016_j_ejrad_2018_08_008
Cites_doi 10.1016/0168-8278(91)90084-O
10.1093/ajcn/59.6.1277
10.1136/gut.2005.069674
10.1148/radiology.153.1.6089263
10.1016/0022-2364(87)90304-0
10.1016/S0079-6565(97)00014-9
10.1016/j.jhep.2005.09.002
10.1053/jhep.2003.50350
10.1002/jmri.20865
10.1136/gut.51.1.89
10.1002/jmri.20831
10.1016/S0399-8320(05)82179-7
10.1053/jhep.2003.50267
10.1016/0730-725X(94)92543-7
10.1148/radiol.2373041639
10.2463/mrms.2.47
10.1038/oby.2002.137
10.1053/jhep.2003.50193
10.1002/hep.510290401
10.1152/ajpendo.1999.276.5.E977
10.1111/j.1463-1326.2005.00543.x
10.1007/s10620-006-3136-9
10.1002/mrm.20825
10.1002/jmri.1880050311
10.1148/radiol.2372040539
10.1016/S0730-725X(00)00168-5
10.2337/diabetes.54.3.603
10.1053/gast.2002.35354
10.2337/diabetes.52.3.701
10.1053/j.gastro.2005.09.015
ContentType Journal Article
Copyright Copyright © 2008 Wiley‐Liss, Inc.
(c) 2008 Wiley-Liss, Inc.
Copyright_xml – notice: Copyright © 2008 Wiley‐Liss, Inc.
– notice: (c) 2008 Wiley-Liss, Inc.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/jmri.21542
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 945
ExternalDocumentID 10_1002_jmri_21542
18821619
JMRI21542
ark_67375_WNG_75WPZ7S0_F
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Wesley Research Institute
– fundername: Princess Alexandra Hospital Research and Development Foundation
– fundername: National Health and Medical Research Council
– fundername: Sasakawa Foundation (Royal Children's Hospital)
– fundername: Queensland Government's Smart State Health and Medical Research Fund
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
ACRPL
ACYXJ
CITATION
7X8
ID FETCH-LOGICAL-c4312-dd349479666a38740754890b2db9965adb68a9ed5bb8c8793f4a9e1e8d3d596b3
IEDL.DBID DR2
ISSN 1053-1807
IngestDate Wed Dec 04 04:44:36 EST 2024
Fri Dec 06 04:46:04 EST 2024
Sat Sep 28 07:46:24 EDT 2024
Sat Aug 24 00:57:01 EDT 2024
Wed Oct 30 09:53:43 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License (c) 2008 Wiley-Liss, Inc.
http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4312-dd349479666a38740754890b2db9965adb68a9ed5bb8c8793f4a9e1e8d3d596b3
Notes Sasakawa Foundation (Royal Children's Hospital)
ark:/67375/WNG-75WPZ7S0-F
Wesley Research Institute
Princess Alexandra Hospital Research and Development Foundation
Queensland Government's Smart State Health and Medical Research Fund
ArticleID:JMRI21542
National Health and Medical Research Council
istex:B95E8E3D2B502CE630D4F193391AD2924216E8C1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18821619
PQID 69650521
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_69650521
crossref_primary_10_1002_jmri_21542
pubmed_primary_18821619
wiley_primary_10_1002_jmri_21542_JMRI21542
istex_primary_ark_67375_WNG_75WPZ7S0_F
PublicationCentury 2000
PublicationDate October 2008
PublicationDateYYYYMMDD 2008-10-01
PublicationDate_xml – month: 10
  year: 2008
  text: October 2008
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: United States
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J. Magn. Reson. Imaging
PublicationYear 2008
Publisher Wiley Subscription Services, Inc., A Wiley Company
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
References Tiikkainen M, Bergholm R, Vehkavaara S, et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 2003; 52: 701-707.
Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12: 487-495.
Poynard T, Ratziu V, McHutchison J, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003; 38: 75-85.
Duman DG, Celikel C, Tuney D, et al. Computed tomography in nonalcoholic fatty liver disease. Dig Dis Sci 2006; 51: 346-351.
Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5: 281-285.
Bressler BL, Guindi M, Tomlinson G, Heathcote J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 2003; 38: 639-644.
Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-1219.
Gronemeyer SA, Steen RG, Kauffman WM, Reddick WE, Glass JO. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging 2000; 18: 815-818.
Oppelt A, Graumann R, Fischer H, Hertl W, Schafor W. FISP: a new fast MRI sequence. Electromedica 1968; 3: 15.
World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation; 1999.
Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R. A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord 1994; 18: 219-234.
Hickman IJ, Clouston AD, Macdonald GA, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002; 51: 89-94.
Kimmich R, Hoepfel D. Volume-selective multipulse spin-echo spectroscopy. J Magn Reson 1987; 72: 379-384.
Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54: 603-608.
Kawamitsu H, Kaji Y, Ohara T, Sugimura K. Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence. Magn Reson Med Sci 2003; 2: 47-50.
Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276: E977-E989.
Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 2006; 44: 197-208.
Pilleul F, Chave G, Dumortier J, et al. Fatty infiltration of the liver. Gastroenterol Clin Biol 2005; 29: 1143-1147.
Carey DG, Cowin GJ, Galloway GJ, et al. Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients. Obes Res 2002; 10: 1008-1015.
Ross R, Shaw KD, Rissanen J, Martel Y, de Guise J, Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994; 59: 1277-1285.
Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374.
Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005; 237: 1048-1055.
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153: 189-194.
Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.
Chan DC, Watts GF, Ng TWK, et al. Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Diabetes Obes Metab 2006; 8: 698-702.
Machann J, Thamer C, Schnoedt B, et al. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 2006; 55: 913-917.
Powell EE, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005; 129: 1937-1943.
Kreis R. Quantitative localized H-1 MR spectroscopy for clinical use. Prog Nucl Magn Reson Spectrosc 1997; 31: 155-195.
Walsh MJ, Jonsson JR, Richardson MM, et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of SOCS-3 in patients with chronic hepatitis C, viral genotype 1. Gut 2005; 55: 529-535.
Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005; 237: 507-511.
Cotler SJ, Guzman G, Jayden-Almer J, et al. Measurement of liver fat content using selective saturation at 3T. J Magn Reson Imaging 2007; 25: 743-748.
Reeder SB, McKenzie CA, Pineda AR, et al. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 2007; 25: 644-562.
2006; 51
1987; 72
1991; 13
1999; 29
2002; 51
2006; 55
1968; 3
2002; 10
2005; 237
2006; 8
2003; 37
2003; 38
2003; 52
2005; 29
1995; 5
1999
2000; 18
1984; 153
1997; 31
2006; 44
2002; 123
2005; 129
1994; 12
2003; 2
2005; 54
1994; 59
1999; 276
1994; 18
2005; 55
2007; 25
e_1_2_5_26_2
e_1_2_5_27_2
e_1_2_5_25_2
Oppelt A (e_1_2_5_17_2) 1968; 3
e_1_2_5_23_2
e_1_2_5_20_2
e_1_2_5_21_2
e_1_2_5_28_2
e_1_2_5_29_2
Chowdhury B (e_1_2_5_22_2) 1994; 18
e_1_2_5_14_2
e_1_2_5_13_2
e_1_2_5_9_2
e_1_2_5_16_2
e_1_2_5_8_2
e_1_2_5_15_2
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_33_2
e_1_2_5_6_2
e_1_2_5_34_2
e_1_2_5_5_2
e_1_2_5_12_2
e_1_2_5_31_2
e_1_2_5_4_2
e_1_2_5_11_2
e_1_2_5_32_2
e_1_2_5_3_2
e_1_2_5_2_2
World Health Organisation (e_1_2_5_24_2) 1999
e_1_2_5_18_2
e_1_2_5_19_2
e_1_2_5_30_2
References_xml – volume: 37
  start-page: 1202
  year: 2003
  end-page: 1219
  article-title: Nonalcoholic steatohepatitis: summary of an AASLD single topic conference
  publication-title: Hepatology
– volume: 8
  start-page: 698
  year: 2006
  end-page: 702
  article-title: Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men
  publication-title: Diabetes Obes Metab
– volume: 25
  start-page: 743
  year: 2007
  end-page: 748
  article-title: Measurement of liver fat content using selective saturation at 3T
  publication-title: J Magn Reson Imaging
– volume: 10
  start-page: 1008
  year: 2002
  end-page: 1015
  article-title: Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients
  publication-title: Obes Res
– volume: 59
  start-page: 1277
  year: 1994
  end-page: 1285
  article-title: Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships
  publication-title: Am J Clin Nutr
– volume: 54
  start-page: 603
  year: 2005
  end-page: 608
  article-title: Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
  publication-title: Diabetes
– volume: 52
  start-page: 701
  year: 2003
  end-page: 707
  article-title: Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content
  publication-title: Diabetes
– volume: 2
  start-page: 47
  year: 2003
  end-page: 50
  article-title: Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence
  publication-title: Magn Reson Med Sci
– volume: 129
  start-page: 1937
  year: 2005
  end-page: 1943
  article-title: Steatosis is a cofactor in liver injury in hemochromatosis
  publication-title: Gastroenterology
– volume: 55
  start-page: 913
  year: 2006
  end-page: 917
  article-title: Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat‐selective MRI and volume‐localized 1H‐MR spectroscopy
  publication-title: Magn Reson Med
– volume: 3
  start-page: 15
  year: 1968
  article-title: FISP: a new fast MRI sequence
  publication-title: Electromedica
– volume: 18
  start-page: 815
  year: 2000
  end-page: 818
  article-title: Fast adipose tissue (FAT) assessment by MRI
  publication-title: Magn Reson Imaging
– volume: 237
  start-page: 1048
  year: 2005
  end-page: 1055
  article-title: Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience
  publication-title: Radiology
– volume: 153
  start-page: 189
  year: 1984
  end-page: 194
  article-title: Simple proton spectroscopic imaging
  publication-title: Radiology
– volume: 25
  start-page: 644
  year: 2007
  end-page: 562
  article-title: Water‐fat separation with IDEAL gradient‐echo imaging
  publication-title: J Magn Reson Imaging
– volume: 237
  start-page: 507
  year: 2005
  end-page: 511
  article-title: Accuracy of liver fat quantification at MR imaging: comparison of out‐of‐phase gradient‐echo and fat‐saturated fast spin‐echo techniques—initial experience
  publication-title: Radiology
– volume: 44
  start-page: 197
  year: 2006
  end-page: 208
  article-title: Non‐alcoholic steatohepatitis: from cell biology to clinical practice
  publication-title: J Hepatol
– volume: 12
  start-page: 487
  year: 1994
  end-page: 495
  article-title: Quantification of liver fat using magnetic resonance spectroscopy
  publication-title: Magn Reson Imaging
– volume: 5
  start-page: 281
  year: 1995
  end-page: 285
  article-title: Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
  publication-title: J Magn Reson Imaging
– volume: 31
  start-page: 155
  year: 1997
  end-page: 195
  article-title: Quantitative localized H–1 MR spectroscopy for clinical use
  publication-title: Prog Nucl Magn Reson Spectrosc
– volume: 38
  start-page: 639
  year: 2003
  end-page: 644
  article-title: High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C
  publication-title: Hepatology
– volume: 72
  start-page: 379
  year: 1987
  end-page: 384
  article-title: Volume‐selective multipulse spin‐echo spectroscopy
  publication-title: J Magn Reson
– volume: 29
  start-page: 1143
  year: 2005
  end-page: 1147
  article-title: Fatty infiltration of the liver
  publication-title: Gastroenterol Clin Biol
– volume: 51
  start-page: 89
  year: 2002
  end-page: 94
  article-title: Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C
  publication-title: Gut
– volume: 51
  start-page: 346
  year: 2006
  end-page: 351
  article-title: Computed tomography in nonalcoholic fatty liver disease
  publication-title: Dig Dis Sci
– volume: 13
  start-page: 372
  year: 1991
  end-page: 374
  article-title: Classification of chronic viral hepatitis: a need for reassessment
  publication-title: J Hepatol
– volume: 38
  start-page: 75
  year: 2003
  end-page: 85
  article-title: Effect of treatment with peginterferon or interferon alfa‐2b and ribavirin on steatosis in patients infected with hepatitis C
  publication-title: Hepatology
– volume: 18
  start-page: 219
  year: 1994
  end-page: 234
  article-title: A multicompartment body composition technique based on computerized tomography
  publication-title: Int J Obes Relat Metab Disord
– volume: 123
  start-page: 745
  year: 2002
  end-page: 750
  article-title: The utility of radiological imaging in nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 276
  start-page: E977
  year: 1999
  end-page: E989
  article-title: Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo
  publication-title: Am J Physiol
– volume: 29
  start-page: 1215
  year: 1999
  end-page: 1219
  article-title: Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
  publication-title: Hepatology
– volume: 55
  start-page: 529
  year: 2005
  end-page: 535
  article-title: Non‐response to antiviral therapy is associated with obesity and increased hepatic expression of SOCS–3 in patients with chronic hepatitis C, viral genotype 1
  publication-title: Gut
– year: 1999
– ident: e_1_2_5_23_2
  doi: 10.1016/0168-8278(91)90084-O
– ident: e_1_2_5_20_2
  doi: 10.1093/ajcn/59.6.1277
– ident: e_1_2_5_7_2
  doi: 10.1136/gut.2005.069674
– ident: e_1_2_5_18_2
  doi: 10.1148/radiology.153.1.6089263
– ident: e_1_2_5_19_2
  doi: 10.1016/0022-2364(87)90304-0
– ident: e_1_2_5_26_2
  doi: 10.1016/S0079-6565(97)00014-9
– ident: e_1_2_5_9_2
  doi: 10.1016/j.jhep.2005.09.002
– ident: e_1_2_5_5_2
  doi: 10.1053/jhep.2003.50350
– ident: e_1_2_5_32_2
  doi: 10.1002/jmri.20865
– ident: e_1_2_5_8_2
  doi: 10.1136/gut.51.1.89
– ident: e_1_2_5_33_2
  doi: 10.1002/jmri.20831
– ident: e_1_2_5_28_2
  doi: 10.1016/S0399-8320(05)82179-7
– ident: e_1_2_5_6_2
  doi: 10.1053/jhep.2003.50267
– volume: 18
  start-page: 219
  year: 1994
  ident: e_1_2_5_22_2
  article-title: A multicompartment body composition technique based on computerized tomography
  publication-title: Int J Obes Relat Metab Disord
  contributor:
    fullname: Chowdhury B
– ident: e_1_2_5_25_2
  doi: 10.1016/0730-725X(94)92543-7
– ident: e_1_2_5_34_2
  doi: 10.1148/radiol.2373041639
– volume-title: Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus
  year: 1999
  ident: e_1_2_5_24_2
  contributor:
    fullname: World Health Organisation
– ident: e_1_2_5_27_2
  doi: 10.2463/mrms.2.47
– ident: e_1_2_5_12_2
  doi: 10.1038/oby.2002.137
– ident: e_1_2_5_2_2
  doi: 10.1053/jhep.2003.50193
– volume: 3
  start-page: 15
  year: 1968
  ident: e_1_2_5_17_2
  article-title: FISP: a new fast MRI sequence
  publication-title: Electromedica
  contributor:
    fullname: Oppelt A
– ident: e_1_2_5_3_2
  doi: 10.1002/hep.510290401
– ident: e_1_2_5_10_2
  doi: 10.1152/ajpendo.1999.276.5.E977
– ident: e_1_2_5_29_2
  doi: 10.1111/j.1463-1326.2005.00543.x
– ident: e_1_2_5_16_2
  doi: 10.1007/s10620-006-3136-9
– ident: e_1_2_5_31_2
  doi: 10.1002/mrm.20825
– ident: e_1_2_5_11_2
  doi: 10.1002/jmri.1880050311
– ident: e_1_2_5_30_2
  doi: 10.1148/radiol.2372040539
– ident: e_1_2_5_21_2
  doi: 10.1016/S0730-725X(00)00168-5
– ident: e_1_2_5_13_2
  doi: 10.2337/diabetes.54.3.603
– ident: e_1_2_5_15_2
  doi: 10.1053/gast.2002.35354
– ident: e_1_2_5_14_2
  doi: 10.2337/diabetes.52.3.701
– ident: e_1_2_5_4_2
  doi: 10.1053/j.gastro.2005.09.015
SSID ssj0009945
Score 2.383037
Snippet Purpose To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Materials and Methods...
To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Quantification of liver fat was...
PURPOSETo compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content.MATERIALS AND...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 937
SubjectTerms Adipose Tissue - pathology
Adult
Biopsy
Fatty Liver - etiology
Fatty Liver - metabolism
Fatty Liver - pathology
fatty liver disease
Female
Humans
Insulin Resistance
liver fat
Magnetic Resonance Imaging - methods
Magnetic Resonance Spectroscopy - methods
Male
Middle Aged
obesity
Obesity - complications
Obesity - metabolism
Obesity - pathology
Reproducibility of Results
Statistics, Nonparametric
Triglycerides - metabolism
weight loss
Title Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
URI https://api.istex.fr/ark:/67375/WNG-75WPZ7S0-F/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.21542
https://www.ncbi.nlm.nih.gov/pubmed/18821619
https://search.proquest.com/docview/69650521
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KBfHFqq02fi609KGQa7K5zSbgi6jXenClVEuLIMt-JOU8Lyn3AbZ_vTObyx2VUtC3BBKy2ZnZ-c3uzG8AdqW2uuRRiUFO5ChAEWEurAl1iRpg0f8ZXx49OE6Pzrr9C3GxBu_bWpiGH2K54UaW4ddrMnBtpgcr0tCf48mwgw6rSwtwnEjK5_t0uuKOynPfoRjxQxLGWSSX3KT8YPXqLW_0gCb2911Q8zZy9a6ntwE_2kE3GSejznxmOvbmLz7H__2rJ_B4gUnZh0aJnsJaUT2Dh4PFqfsm9Af6sqJiR4axeU0MHQUbjn17I6Yrx3y1JrFi1lfXDEEwG_uFgnYM2S_K-2CkSrN6OpxuwVnv87ePR-GiB0NoEVrw0Dnir5EYFKU6ofZ9EkOcPDLcGYyUhHYoS50XThiT2QyNvezibVxkLnEiT03yHNaruiq2gTnL48KVObcm6iZWZlbKVMTGpUSBxW0AO60s1FVDtaEaUmWuaFqUn5YA9ryYlo_oyYiS06RQ58eHSorzk-_ya6R6Abxr5ajQZOgcRFdFPZ-qFAdONcsBvGjEu_ocxhsIgfMA9r2Q7hmH6g9Ov_irl__y8Ct4xFtG3fg1rM8m8-INwpqZeevV9w9KefKi
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9KC9Uvan3GR7ug-EHINdncZpOPol6vZ3NIbWnxy7KPRM56SbkH2P71zmzuQaUI-i2BhGx2ZnZ-szvzG4A3Ultd8ajCICdyFKCIMBfWhLpCDbDo_4wvjy6Gaf-0OzgX54vcHKqFafkhVhtuZBl-vSYDpw3p_TVr6I_xZNRBj9XFFXgL7T2mjK6Px2v2qDz3PYoRQSRhnEVyxU7K99fv3vBHWzS1v24Dmzexq3c-vftth9Wp5yyknJOLznxmOvb6D0bH__6vB3BvAUvZ-1aPdmCjrB_CdrE4eH8Eg0J_r6nekWF43hBJR8lGY9_hiOnaMV-wScSYzeUVQxzMxn6toE1D9pNSPxhp06yZjqaP4bT36eRDP1y0YQgtogseOkcUNhLjolQn1MFPYpSTR4Y7g8GS0A7FqfPSCWMym6G9V128jcvMJU7kqUmewGbd1OUzYM7yuHRVzq2JuomVmZUyFbFxKbFgcRvA66Uw1GXLtqFaXmWuaFqUn5YA3no5rR7RkwvKT5NCnQ0PlBRnX77Jr5HqBbC3FKRCq6GjEF2XzXyqUhw4lS0H8LSV7_pzGHIgCs4DeOel9JdxqEFxfOivnv_Lw3twp39SHKmjw-HnF3CXLwl245ewOZvMy1eIcmZm1-vyb4Dn9sM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9KC8Uvvh_x1QXFD0KuyeaxWfCLWM_29I5SLS1CWfaRyFkvOe4B6l_vzOZyR0UE_ZbALtnszOz8ZnfnNwDPhba64lGFQU7kKEDJQplZE-oKNcCi_zM-PXo4yg9P08F5dr4Fr7pcmJYfYr3hRpbh12sy8Kmr9jekoV8ns3EPHVaKC_BOmnNJzPkHJxvyKCl9iWIEEEkYF5FYk5Py_U3fK-5oh2b2-5-w5lXo6n1P_wZcdKNur5xc9pYL07M_fyN0_N_fugnXV6CUvW616BZslfVt2B2ujt3vwGCov9SU7cgwOG-IoqNk44mvb8R07ZhP1yRazGb6gyEKZhO_UtCWIftGFz8Y6dKimY_nd-G0__bTm8NwVYQhtIgteOgcEdgIjIpynVD9PoExjowMdwZDpUw7FKaWpcuMKWyB1l6l-BqXhUtcJnOT3IPtuqnLB8Cc5XHpKsmtidLEisIKkWexcTlxYHEbwLNOFmracm2ollWZK5oW5aclgBdeTOsmenZJt9NEps5G75TIzo4_i4-R6gew18lRoc3QQYiuy2Y5VzkOnJKWA7jfinfzOQw4EAPLAF56If1lHGowPDnyTw__pfEe7B4f9NWHo9H7R3CNd-y68WPYXsyW5ROEOAvz1GvyL6qk9XI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Magnetic+resonance+imaging+and+spectroscopy+for+monitoring+liver+steatosis&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Cowin%2C+Gary+J&rft.au=Jonsson%2C+Julie+R&rft.au=Bauer%2C+Judith+D&rft.au=Ash%2C+Susan&rft.date=2008-10-01&rft.issn=1053-1807&rft.volume=28&rft.issue=4&rft.spage=937&rft.epage=945&rft_id=info:doi/10.1002%2Fjmri.21542&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon